Viewing nowCombinationCozaplus F Tablets
Losartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.

MFDS item code 200807469 · Notified 2008.07.07 · Insurance code 073100350
Treatment of hypertension not controlled by monotherapy
This medication is used for patients with hypertension whose blood pressure is not adequately controlled with monotherapy. It effectively lowers blood pressure, reducing the burden on the cardiovascular system and helping to prevent complications.
○ Adults The usual dose of this drug is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not advisable. In general, the maximum blood pressure-lowering effect occurs approximately 3 weeks after starting treatment. This drug may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start this drug only when the expected effect has not been achieved with monotherapy. 1. Substitution therapy: This drug may replace combination therapy with individually dose-adjusted losartan potassium and hydrochlorothiazide. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia despite blood pressure control at this dose: Treatment may be initiated with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which reduces the hydrochlorothiazide dose without reducing the overall blood pressure-lowering effect. Continue to monitor the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg; if blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment Use the usual dose when creatinine clearance is 30 mL/min or greater. Administration is not recommended in patients with more severe renal impairment, as loop diuretics are preferable to thiazide drugs in these patients. ○ Patients with hepatic impairment Administration is not recommended in patients with hepatic impairment requiring dose adjustment, because the initial dose of losartan potassium for these patients, 25 mg, cannot be administered using this drug.
○ Children (under 18 years) There is no experience with use in children and adolescents; therefore, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.
This drug can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. There is a risk of complications for the fetus during pregnancy, such as decreased lung development, skeletal malformations, decreased skull formation, and renal failure, which can even lead to neonatal death. This medication should not be administered to patients with certain conditions, for example, those with anuria, severe liver dysfunction, severe kidney dysfunction, or allergies to sulfonamide drugs. Patients with electrolyte imbalances, such as hyperuricemia, gout, hypokalemia, hypercalcemia, and hyponatremia, should be careful. Elderly patients and those with cardiovascular diseases, cerebrovascular disorders, or diabetes may experience excessive hypotensive effects or worsening conditions, so treatment should be cautious. This medication affects potassium concentration, so taking it with potassium supplements or potassium-sparing diuretics may be dangerous; consultation with a doctor is required before taking. During treatment, blood pressure, kidney function, and electrolyte levels should be regularly monitored to ensure no abnormalities occur. Dizziness or drowsiness may occur while taking this medication, so caution is necessary when driving or operating machinery. If any abnormal skin reactions or new skin lesions appear, inform medical personnel immediately, and avoid sun exposure and ensure adequate UV protection. In the case of overdose, symptoms may include hypotension and arrhythmias, and medical attention should be sought immediately. This drug is not to be used in children and adolescents due to insufficient experience. Breastfeeding women should stop breastfeeding or consult with a doctor before using this medication, as it may be transmitted through breast milk. It is advisable to avoid grapefruit juice during treatment, and potential drug interactions should be discussed with healthcare providers if other medications are being taken. Finally, store this medication out of the reach of children and keep it in its original container to prevent misuse or quality deterioration.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that protects it from light. Additionally, it is best to store the medication in a cool room at a temperature between 1 degree and 30 degrees Celsius.
Light yellow oval film-coated tablets, engraved with '747' on one side.
30 tablets (10 tablets/PTP x 3 PTP), 100 tablets (100 tablets/bottle)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.